Thursday , October 17 2019
Home / portugal / The medical use of cannabis may be approved by the Senate Committee

The medical use of cannabis may be approved by the Senate Committee



Cannabis
Cannabis

This Thursday (26) the Senate Human Rights Commission will decide whether or not to regulate the use of curative cannabis in Brazil. The proposal comes from the Brazilian Network for Harm Reduction and Human Rights (Reduction), which also advocates the use of hemp fiber from the plant.

Marijuana (Cannabis sativa) is a plant known to have a variety of chemicals and has components with healing properties, such as Cannabidiol (HBD). Despite its therapeutic potential, the plant is also one of the most controversial drugs because it provides psychotropic side effects due to its main components, Tetrahydrocannabinol (TF), which causes effects on the central nervous system.

According to the Ipsos Global Views on Vices 2019 survey, for 57% of Brazilians, moderate use of marijuana is not morally acceptable. This rate is close to that recorded in the world (51%). However, for 24% of respondents in Brazil, this attitude is morally acceptable, slightly above the global (22%).

The proposal, signed in 2016, is due back this week and has 133 articles with procedural and regulatory rules on methods of research, production, registration, labeling, standardization, marketing, advertising, inspection control, among other details. In relation to planting, cultivation and harvesting of industrial hemp, the substitution stipulates, even if the rules are the responsibility of the State agricultural authority.

Senator Alessandro Vieira (Kidania / EC) is in favor of the proposal, following some changes proposed in the text.
Senator Alessandro Vieira (Kidania / EC) is in favor of the proposal, following some changes proposed in the text.

The rapporteur's opinion, Senator Alessandro Viera (Citadel / EC) is for approval of the proposal after some changes have been made. In an exclusive interview with the Nation, the lawmaker says misinformation makes the debate more moral than scientific. "Effectively, worldwide, what is protected is the production of plants with a low FHC index and a high rate of CBD, a substance with high healing power. I think there is a very bad moral denial. We have already expressed an opinion that does not approve of recreational use and, in Brazil, we already have people using cannabidiol-based medicines (CBD) without a problem list, "he reveals.

In 2015, Anvisa removed cannabidiol from the list of prohibited substances in Decree 344 and transferred that substance to a list of substances subject to special control (subject to two-way special prescription control) on the same regulation. Thus, it is now permissible to import drugs having a maximum of 30 mg of tetrahydrocannabinol (TF) per milliliter and 30 mg of cannadiol per milliliter. Because of this change, even the registration of drugs, Mevatic, happened.

In June, Anvisa also published, in the Federal Office Gazette, two proposals for a public consultation related to the regulation of controlled cultivation of cannabis sativa for medical and scientific use and registration of drugs produced with active plant ingredients.

"We are trying to provide a cure to people who are suffering. Congress held a public hearing in the House and Senate with professionals from the University of Sоo Paulo (USP) on the subject in support of the release. What is happening is trying to confuse the use of the drug with the real drug for extracts, ”the reporter says.

Clash

According to Hirjo, the proposal opens the door to insurmountable cannabis use in Brazil.
According to Hirjo, the proposal opens the door to insurmountable cannabis use in Brazil.

On Thursday, senators will also discuss a separate vote to reject the initiative. The proposal comes from Ceará Eduardo Girão (Somos), who believes the release is harmful, mainly from the consumption of tetrahydrocannabinol (TF). In one note, the parliamentarian outlines the reasons. Check out the full:

"Marijuana has over 500 active substances, including over 100 cannabinoids. CKD (Cannabidiol) and TF (Tetrahydrocannabinol) are the most studied by scientists, who have found that CKD has no hallucinogenic effects, does not cause chemical dependence, and can be used to treat diseases such as multiple sclerosis and particularly refractory neurological disorders. that cause attacks.

In fact, there is already a mass production of cannabidiol-based drugs that are sold in several countries around the world. And the best: Anvisa allows import to Brazil by prescription.

THC is different and dangerous. Causes addiction and hallucinations, although studies indicate some therapeutic effects, THC has numerous harmful effects, especially when absorbed by children and adolescents: memory impairment, attention deficit disorder, depression, anxiety, schizophrenia, etc.

Therefore, it has been scientifically proven that out of 500 marijuana substances only one, CBD has the only beneficial effects on human health. We advocate for the exclusive use of CBD in medical treatment through drugs subject to the required testing protocols. After all, it is not fair for a child to have to consume another cannabis substance to benefit from only one of them.

Since it is an expensive treatment, we also understand that the Unified Health System (SUS) should be responsible for obtaining and distributing these substances based on HBD, I was admitted last week (09/18/2019) to a project requiring SUS to provide cannabidiol based products to those who cannot afford the therapeutic resource. "

In his social networks, the senator said that, in Brazil, there was an attempt to classify marijuana as "medical" and thereby free up planting at home for treatment of diseases. "I will also fight for our people not to be deceived by false promises of treatment that actually open the door to uncontrolled cannabis use, a drug that poses so many risks to our youth," the parliamentarian said in a video posted to Instagram. .

Click on the image to open a gallery








Source link